1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Ranibizumab: new trials by email Literature Review of Ranibizumab trials Research Report on Ranibizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity Ranibizumab (0.25 mg/0.025 mL) - Retina Disease, Retinopathy of Prematurity | Phase 3 | Completed | Zagazig University | 30 | 2020-11-20 | 2023-01-30 |
Retinopathy of Prematurity (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases (1) · Infant, Newborn, Diseases (1) · Infant, Premature, Diseases (1) · Retinal Diseases (1)
Ranibizumab (1)
Egypt (1)